Amy Jordan

Title: Amy Jordan - Innovator in Glycine Transporter Inhibition

Introduction

Amy Jordan is a notable inventor based in Parma, Ohio. She has made significant contributions to the field of pharmaceutical sciences, particularly in the area of glycine transporters. Her innovative work has led to the development of compounds that have potential therapeutic applications.

Latest Patents

Amy Jordan holds 1 patent for her invention titled "Substituted hydrazine derivatives." This patent describes a method for the inhibition of high-affinity glycine transporters. The invention includes compounds that inhibit these transporters, as well as pharmaceutically active compositions comprising such compounds. The use of these compounds is aimed at controlling or preventing disease states in which glycine is involved.

Career Highlights

Amy Jordan is currently employed at Merck & Co., Inc., a leading global healthcare company. Her role at Merck allows her to work on cutting-edge research and development projects that aim to improve patient outcomes through innovative therapies.

Collaborations

Throughout her career, Amy has collaborated with esteemed colleagues, including Syed M Ali and Kurt R Brunden. These collaborations have further enhanced her research and contributed to the advancement of her inventions.

Conclusion

Amy Jordan's work in the field of glycine transporter inhibition exemplifies her dedication to innovation in pharmaceuticals. Her contributions are paving the way for new therapeutic options that could significantly impact healthcare.